BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24026506)

  • 1. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
    Ressler KJ; Rothbaum BO
    JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD.
    O'Neill J
    Evid Based Ment Health; 2014 May; 17(2):58-9. PubMed ID: 24713316
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
    Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
    Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent.
    Ramasubbu R
    Arch Gen Psychiatry; 2002 May; 59(5):472; author reply 472-3. PubMed ID: 11982460
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
    Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
    Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2003 Dec; (10):1172-87. PubMed ID: 15555141
    [No Abstract]   [Full Text] [Related]  

  • 9. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2004 Jun; (11):1319-34. PubMed ID: 15652061
    [No Abstract]   [Full Text] [Related]  

  • 10. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2005 Dec; (14):1270-83. PubMed ID: 16620454
    [No Abstract]   [Full Text] [Related]  

  • 11. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
    Okada T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
    [No Abstract]   [Full Text] [Related]  

  • 12. A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.
    Brakoulias V; Stockings E
    Expert Opin Pharmacother; 2019 Jan; 20(1):47-53. PubMed ID: 30360669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of risperidone-induced obsessive-compulsive symptoms.
    Alzaid K; Jones BD
    J Clin Psychopharmacol; 1997 Feb; 17(1):58-9. PubMed ID: 9004062
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent.
    Pathak S; Cottingham EM; McConville BJ
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S93-4. PubMed ID: 12880505
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.
    Yamauchi K; Ohta K; Taniguchi T; Ohmori T
    Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355
    [No Abstract]   [Full Text] [Related]  

  • 17. Alcohol binge drinking in OCD: A compulsive ritualistic behaviour to counter magical thinking.
    Dwivedi S; Kar SK
    Asian J Psychiatr; 2017 Oct; 29():160-161. PubMed ID: 29061418
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of OCD].
    Sumitani S; Ohmori T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):442-5. PubMed ID: 12877022
    [No Abstract]   [Full Text] [Related]  

  • 19. Obsessive-compulsive disorder presenting with gender incongruence obsessions.
    Uvais NA; Sreeraj VS
    Asian J Psychiatr; 2017 Dec; 30():77-78. PubMed ID: 28837942
    [No Abstract]   [Full Text] [Related]  

  • 20. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
    Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
    Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.